{
    "Trade/Device Name(s)": [
        "FreeStyle Precision Neo Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Abbott Diabetes Care, Inc.",
    "510(k) Number": "K142928",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140371"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "September 2, 2015",
    "Summary Letter Received Date": "September 4, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FreeStyle Precision Neo Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry",
        "Glucose Dehydrogenase (GDH) enzymatic reaction"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Accessory",
        "Control Solution",
        "Lancing Device",
        "Lancet",
        "Cable"
    ],
    "Document Summary": "FDA 510(k) summary for FreeStyle Precision Neo Blood Glucose Monitoring System using amperometric glucose measurement for self-testing by lay users.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh whole blood from the fingertip for self-testing by lay users in home diabetes management; not for neonatal or diabetes screening/diagnosis; single-person use only.",
    "fda_folder": "Clinical Chemistry"
}